Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2012

01-03-2012 | Short Communication

Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery: case report and literature review

Authors: Gabriella De Rosa, Maria Giuseppina Cefalo, Riccardo Marano, Marco Piastra, Angelica Bibiana Delogu, Donato Rigante

Published in: Rheumatology International | Issue 3/2012

Login to get access

Abstract

A 7-year-old child was first admitted for persistent fever of 15-day duration and suspected meningitis. Kawasaki syndrome was lately diagnosed upon the recognition of an extensive diffuse coronary artery damage characterized by medium-sized aneurysms of the epicardial vessels. An eccentric thrombus along the inferior wall of the left anterior descending artery suspected at transthoracic echocardiography was confirmed by coronary computed tomography angiography scan, without significant segmental stenosis. Strict cardiac surveillance and anticoagulant therapy were maintained, and no ischemic complications occurred at a short-term follow-up. This report emphasizes that thrombosis can be observed even in medium-sized aneurysms when the diagnosis of Kawasaki syndrome is delayed.
Literature
1.
Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222PubMed
2.
Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W (1994) Guidelines for long-term management of patients with Kawasaki disease: report from the Committee on rheumatic fever, endocarditis and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Circulation 89:916–922PubMed
3.
4.
Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347PubMedCrossRef
5.
6.
Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL (2008) Kawasaki disease: an overview. Curr Opin Infect Dis 21:263–270PubMedCrossRef
7.
Anderson MS, Todd JK, Glode MP (2005) Delayed diagnosis of Kawasaki syndrome. An analysis of the problem. Pediatrics 115:e428–e433PubMedCrossRef
8.
De Rosa G, Pardeo M, Rigante D (2007) Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci 11:301–308PubMed
9.
Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, De Nisco A, Angelone DF, Compagnone A, Delogu AB (2010) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-centre cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30:841–846PubMedCrossRef
10.
Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J (2007) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. J Cardiovasc Nurs 22:218–253PubMed
11.
Hirose K, Nakamura Y, Yanagawa H (1995) Cardiac sequelae of Kawasaki disease in Japan over 10 years. Acta Paediatr Jpn 37:667–671PubMed
12.
Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, Printz BF, Klein GL, Sundel RP, Takahashi M, Li JS, Vetter VL, Newburger JW, Pediatric Heart Network Investigators (2007) Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics 120:e1434–e1440PubMedCrossRef
13.
Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H (2004) Use of laboratory data to identify risk factors of giant coronary artery aneurysms due to Kawasaki disease. Pediatr Int 46:33–38PubMedCrossRef
14.
Nakano H, Uewda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 56:846–851PubMedCrossRef
15.
Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kawamura S, Kimura K (1994) Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 74:822–824PubMedCrossRef
16.
Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061PubMed
17.
Japanese Circulation Society Joint Research Group (2005) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int 47:711–732CrossRef
18.
19.
Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S (2005) Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 26:73–79PubMedCrossRef
20.
Ohkubo T, Fukazawa R, Ikegami E, Ogawa S (2007) Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations. Pediatr Int 49:1–7PubMedCrossRef
21.
Alloul S, Dahdah N, Miró J (2009) Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal. Pediatr Cardiol 30:188–190PubMedCrossRef
22.
Sohn S, Kwon K (2008) Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin. Pediatr Cardiol 29:153–156PubMedCrossRef
23.
La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet’s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71–77PubMed
24.
Zhuang J, Wang S, Zhang Z, Zeng S, Shi Y, Nong S (2008) Acute myocardial infarction and ascending aortic aneurysm in a child with Behçet’s disease. Turk J Pediatr 50:81–85PubMed
25.
Cook AL, Rouster-Stevens K, Williams DA, Hines MH (2010) Giant aneurysm of the left anterior descending coronary artery in a pediatric patient with Behcet’s disease. Pediatr Cardiol 31:700–702PubMedCrossRef
26.
Rigante D, Valentini P, Onesimo R, Angelone DF, De Nisco A, Bersani G, Delogu AB (2010) Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome. Rheumatol Int 30:535–539PubMedCrossRef
27.
Kumar S, Vaidyanathan B, Gayathri S, Rajam L (2010) Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int [Epub ahead of print]
28.
Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, Weindling SN, Newburger JW, Sundel RP (2005) Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 116:e89–e93PubMedCrossRef
29.
Rigante D, La Torraca I, Rossodivita A, De Rosa G, Pantanella A, Delogu AB, Gaspari S, Stabile A (2007) Unilateral cervical mass as a main clue raising the diagnostic suspicion of Kawasaki syndrome. Rheumatol Int 28:73–76PubMedCrossRef
30.
Thapa R, Chakrabartty S (2009) Atypical Kawasaki disease with remarkable paucity of signs and symptoms. Rheumatol Int 29:1095–1096PubMedCrossRef
Metadata
Title
Delayed diagnosis of Kawasaki syndrome and thrombosis of a medium-sized aneurysm of the anterior descending coronary artery: case report and literature review
Authors
Gabriella De Rosa
Maria Giuseppina Cefalo
Riccardo Marano
Marco Piastra
Angelica Bibiana Delogu
Donato Rigante
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1814-1

Other articles of this Issue 3/2012

Rheumatology International 3/2012 Go to the issue

Original Article

Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics

Case Report

Transient involvement of the cerebral cortex in a flare of Behçet’s syndrome

Case Report

Tongue infarction as first symptom of temporal arteritis

Original Article

Nine cases of Alkaptonuria in one family in southern Jordan

Short Communication

A case of primary Sjögren’s syndrome presenting primarily with central nervous system vasculitic involvement

Original Article

Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits